---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-007397"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2022-01-25T23:59:59+00:00"
generated_at: "2026-06-27T16:05:39.084840+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aptar appoints Gael Touya as President of Pharma Segment; board classes rebalanced

## Summary
- Effective Jan 1, 2022, Gael Touya appointed President of Pharma Segment, reporting to CEO Stephan Tanda.
- Touya will be based in Congers, NY, on a 3-year assignment (max 5 years).
- Compensation includes expatriate benefits: housing, car, education, travel, tax equalization.
- His French employment contract with Aptar Europe Holding SAS suspended for assignment duration.
- Board rebalanced classes after death of director Joanne Smith; Candace Matthews shifted to 2023 term.

## SEC filing metadata
- accession: 0001104659-22-007397
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2022-01-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000110465922007397/0001104659-22-007397-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000110465922007397/tm224376d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-007397
- JSON: https://secwatch.observer/filing/0001104659-22-007397.json
- Plain text: https://secwatch.observer/filing/0001104659-22-007397.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.